Sun Pharmaceutical Industries Ltd, India’s largest drugmaker and a global leader in specialty generics, has appointed Kirti Ganorkar as its new Managing Director. The appointment became effective on May 29, 2025, and is set for a five-year term, pending shareholder approval.
Ganorkar currently serves as the CEO of India Business at Sun Pharma and has been associated with the company in senior leadership roles for nearly two decades. His elevation marks a strategic leadership transition aimed at consolidating Sun Pharma’s dominance in the Indian market and expanding its global presence.
Kirti Ganorkar – A Veteran in the Pharma Industry
Kirti Ganorkar is a seasoned executive with over 30 years of experience in the pharmaceutical sector. He has deep expertise in marketing, business strategy, product lifecycle management, and operations. During his tenure as CEO of the India business, Sun Pharma strengthened its position as the market leader in several therapeutic areas, including cardiology, dermatology, and diabetology.
Under his leadership, the India business has witnessed consistent double-digit growth, with successful product launches and strong partnerships with healthcare professionals and distributors.
Strategic Focus for the Future
In his new role, Ganorkar is expected to focus on:
- Expanding Sun Pharma’s specialty medicines portfolio, especially in regulated markets like the US and Europe.
- Driving innovation through R&D and digital transformation.
- Enhancing efficiencies across global operations and supply chains.
- Strengthening the company’s compliance and ESG (Environmental, Social, Governance) practices.
Sun Pharma has stated that Ganorkar’s appointment is part of its ongoing commitment to build a future-ready organisation and deliver sustained value to patients, partners, and shareholders.
Board’s Confidence in Ganorkar’s Leadership
The board of Sun Pharma expressed confidence in Ganorkar’s proven leadership abilities, strong industry understanding, and people-first approach. His appointment comes at a crucial time when the company is entering new markets and scaling its innovation capabilities in biologics, complex generics, and chronic therapies.
About Sun Pharma
Founded in 1983, Sun Pharmaceutical Industries Ltd is headquartered in Mumbai and operates in over 100 countries. The company ranks among the top 10 global generic pharmaceutical companies and is a market leader in India.
